Preliminary results from a phase II study of lenalidomide oral monotherapy in relapsed/refractory aggressive non-Hodgkin lymphoma

被引：0
|
作者：
Wiernik, P. H.
Lossos, I. S.
Tuscano, J.
Justice, G.
Vose, J. M.
Pietronigro, D.
Takeshita, K.
Ervin-Haynes, A.
Zeldis, J.
Habermann, T.
机构：
[1] New York Med Coll, Bronx, NY USA
[2] Univ Miami, Miami, FL USA
[3] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA
[4] Pacific Coast Hematol Oncol Med Grp, Fountain Valley, CA USA
[5] Univ Nebraska, Omaha, NE 68182 USA
[6] Celgene Corp, Summit, NJ USA
[7] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8052
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial
    Changhee Park
    Ho Sup Lee
    Ka-Won Kang
    Won-Sik Lee
    Young Rok Do
    Jae-Yong Kwak
    Ho-Jin Shin
    Sung-Yong Kim
    Jun Ho Yi
    Sung-Nam Lim
    Jeong-Ok Lee
    Deok-Hwan Yang
    Hun Jang
    Byoungsan Choi
    Jiwoo Lim
    Choong Hyun Sun
    Ja Min Byun
    Sung-Soo Yoon
    Youngil Koh
    Nature Communications, 15
  • [42] A Phase II Multicenter Study of Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma.
    Fehniger, Todd A.
    Larson, Sarah
    Trinkaus, Kathryn
    Siegel, Marilyn J.
    Cashen, Amanda F.
    Blum, Kristie A.
    Fenske, Timothy S.
    Hurd, David D.
    Goy, Andre
    DiPersio, John F.
    Bartlett, Nancy L.
    BLOOD, 2009, 114 (22) : 1422 - 1422
  • [43] A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma
    Fehniger, Todd A.
    Watkins, Marcus P.
    Ezenwajiaku, Nkiruka
    Wan, Fei
    Hurd, David D.
    Cashen, Amanda F.
    Blum, Kristie A.
    Goy, Andre
    Fenske, Timothy S.
    Wagner-Johnston, Nina D.
    Carson, Kenneth
    Siegel, Marilyn J.
    Russler-Germain, David
    Schneider, Stephanie E.
    Mehta-Shah, Neha
    Kahl, Brad
    Bartlett, Nancy L.
    HAEMATOLOGICA, 2024, 109 (03) : 953 - 957
  • [44] Phase I/II Study of Dasatinib In Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)
    William, Basem M.
    Hohenstein, Maribeth
    Loberiza, Fausto R., Jr.
    Caponetti, Gabriel C.
    Bociek, R. Gregory
    Bierman, Philip
    Armitage, James O.
    Chan, Wing-Chung
    Vose, Julie M.
    BLOOD, 2010, 116 (21) : 131 - 131
  • [45] Updated Results of a Phase I Study of Ibrutinib and Lenalidomide in Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma
    Christian, Beth A.
    Kuruvilla, John G.
    Smith, Sonali M.
    Porcu, Pierluigi
    Maddocks, Kami J.
    Ruppert, Amy S.
    Byrd, John C.
    Grever, Michael R.
    Blum, Kristie A.
    BLOOD, 2015, 126 (23)
  • [46] Pixantrone: A Review in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
    Keating, Gillian M.
    DRUGS, 2016, 76 (16) : 1579 - 1586
  • [47] Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial
    Park, Changhee
    Lee, Ho Sup
    Kang, Ka-Won
    Lee, Won-Sik
    Do, Young Rok
    Kwak, Jae-Yong
    Shin, Ho-Jin
    Kim, Sung-Yong
    Yi, Jun Ho
    Lim, Sung-Nam
    Lee, Jeong-Ok
    Yang, Deok-Hwan
    Jang, Hun
    Choi, Byoungsan
    Lim, Jiwoo
    Sun, Choong Hyun
    Byun, Ja Min
    Yoon, Sung-Soo
    Koh, Youngil
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [48] Cologne high-dose sequential chemotherapy in relapsed and refractory aggressive Non-Hodgkin's lymphoma - Results of multicenter phase II study.
    Josting, A
    Sieniawski, M
    Staak, O
    Glossmann, JP
    Diehl, V
    Engert, A
    BLOOD, 2003, 102 (11) : 405A - 405A
  • [49] Lenalidomide response in relapsed/refractory aggressive non-Hodgkin's lymphoma is related to tumor burden and time from rituximab treatment
    Wiernik, Peter H.
    Lossos, Izidore S.
    Tuscano, Joseph M.
    Justice, Glen
    Vose, Julie M.
    Cole, Craig E.
    McBride, Kyle
    Wride, Kenton
    Pietronigro, Dennis
    Takeshita, Kenichi
    Ervin-Haynes, Annette
    Zeldis, Jerome B.
    Habermann, Thomas M.
    BLOOD, 2007, 110 (11) : 756A - 756A
  • [50] Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma
    Ribrag, Vincent
    Caballero, Dolores
    Ferme, Christophe
    Zucca, Emanuele
    Arranz, Reyes
    Briones, Javier
    Gisselbrecht, Christian
    Salles, Gilles
    Gianni, Alessandro M.
    Gomez, Henry
    Kahatt, Carmen
    Corrado, Claudia
    Szyldergemajn, Sergio
    Extremera, Sonia
    de Miguel, Bernardo
    Cullell-Young, Martin
    Cavalli, Franco
    HAEMATOLOGICA, 2013, 98 (03) : 357 - 363
12345